Schedule I [21 CFR 1308.11]
Source: Shulgin, Alexander T. Controlled Substances: Chemical & Legal Guide to Federal Drugs Laws (2nd edition). Ronin Publishing Inc., Berkeley, 1992
Source: DEA Office of Diversion Control: Section 1308: Schedules of Controlled Substances
(b)
Opiates. Unless specifically excepted or unless listed in another schedule, any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters and ethers, whenever the existence of such isomers, esters, ethers and salts is possible within the specific chemical designation (for purposes of paragraph (b)(34) only, the term isomer includes the optical and geometric isomers):
Effective 29 May 1987, 52 FR 20070 added (and renumbered subsequent entries):
(1)
9815
Acetyl-alpha-methylfentanyl (N-[1-(1-Methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide)
CA: CDSA Schedule I Section 16 Subsection 1 Acetyl-α-methylfentanyl
UK: MDA Part I Class A Section 1(d) Acetyl-α-methylfentanyl
UN: Narcotics Part 1 Section 1 Acetyl-alpha-methylfentanyl and Section 3 Acetyl-alpha-methylfentanyl
(2)
9601
Acetylmethadol
CA: CDSA Schedule I Section 6 Subsection 1 Acetylmethadol
UK: MDA Part I Class A Section 1(a) Methadyl acetate
UN: Narcotics Part 1 Section 1 Acetylmethadol
Effective 23 Jan 1987, 52 FR 2516 revoked (and renumbered subsequent entries):
Effective 24 Aug 1984, 49 FR 25849 added (and renumbered subsequent entries):
9737
Alfentanil
US: Currently at CSA Schedule II Section c Subsection 1 Alfentanil
(3)
9602
Allylprodine
CA: CDSA Schedule I Section 3 Subsection 1 Allylprodine
UK: MDA Part I Class A Section 1(a) Allylprodine
UN: Narcotics Part 1 Section 1 Allylprodine
(4)
9603
Alphacetylmethadol (except levo-Alphacetylmethadol also known as levo-Alpha-acetylmethadol, Levomethadyl acetate, or LAAM)
Effective 18 Aug 1993, 58 FR 43795 replacement for:
Alphacetylmathadol [sic]
CA: CDSA Schedule I Section 6 Subsection 2 Alphacetylmethadol
UK: MDA Part I Class A Section 1(a) Alphacetylmethadol
UN: Narcotics Part 1 Section 1 Alphacetylmethadol
(5)
9604
Alphameprodine
CA: CDSA Schedule I Section 3 Subsection 2 Alphameprodine
UK: MDA Part I Class A Section 1(a) Alphameprodine
UN: Narcotics Part 1 Section 1 Alphameprodine
(6)
9605
Alphamethadol
CA: CDSA Schedule I Section 6 Subsection 3 Alphamethadol
UK: MDA Part I Class A Section 1(a) Alphamethadol
UN: Narcotics Part 1 Section 1 Alphamethadol
Effective 22 Sep 1981, 46 FR 46799 added (and renumbered subsequent entries):
(7)
9814
Alpha-methylfentanyl (N-[1-(Alpha-methyl-beta-phenyl)ethyl-4-piperidyl]propionanilide; 1-(1-Methyl-2-phenylethyl)-4-(N-propanilido)piperidine)
CA: CDSA Schedule I Section 16 Subsection 8 α-Methylfentanyl
UK: MDA Part I Class A Section 1(d) α-Methylfentanyl
UN: Narcotics Part 1 Section 1 Alpha-Methylfentanyl and Section 3 Alpha-Methylfentanyl
Effective 29 May 1987, 52 FR 20070 added (and renumbered subsequent entries):
(8)
9832
Alpha-methylthiofentanyl (N-[1-Methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide)
CA: CDSA Schedule I Section 16 Subsection 9 α-Methylthiofentanyl
UK: MDA Part I Class A Section 1(d) α-Methylthiofentanyl
UN: Narcotics Part 1 Section 1 Alpha-Methylthiofentanyl and Section 3 Alpha-Methylthiofentanyl
(9)
9606
Benzethidine
CA: CDSA Schedule I Section 3 Subsection 7 Benzethidine
UK: MDA Part I Class A Section 1(a) Benzethidine
UN: Narcotics Part 1 Section 1 Benzethidine
(10)
9607
Betacetylmethadol
CA: CDSA Schedule I Section 6 Subsection 4 Betacetylmethadol
UK: MDA Part I Class A Section 1(a) Betacetylmethadol
UN: Narcotics Part 1 Section 1 Betacetylmethadol
Effective 29 May 1987, 52 FR 20070 added (and renumbered subsequent entries):
(11)
9830
Beta-hydroxyfentanyl (N-[1-(2-Hydroxy-2-phenethyl)-4-piperidinyl]-N-phenylpropanamide)
CA: CDSA Schedule I Section 16 Subsection 6 β-Hydroxyfentanyl
UK: MDA Part I Class A Section 1(d) β-Hydroxyfentanyl
UN: Narcotics Part 1 Section 1 Beta-Hydroxyfentanyl and Section 3 Beta-Hydroxyfentanyl
Effective 8 Jan 1988, 53 FR 500 added (and renumbered subsequent entries):
(12)
9831
Beta-hydroxy-3-methylfentanyl (N-[1-(2-Hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide)
CA: CDSA Schedule I Section 16 Subsection 7 β-Hydroxy-3-methylfentanyl
UK: MDA Part I Class A Section 1(d) β-Hydroxy-3-methylfentanyl
UN: Narcotics Part 1 Section 1 Beta-Hydroxy-3-methylfentanyl and Section 3 Beta-Hydroxy-3-methylfentanyl
(13)
9608
Betameprodine
CA: CDSA Schedule I Section 3 Subsection 5 Betameprodine
UK: MDA Part I Class A Section 1(a) Betameprodine
UN: Narcotics Part 1 Section 1 Betameprodine
(14)
9609
Betamethadol
CA: CDSA Schedule I Section 6 Subsection 5 Betamethadol
UK: MDA Part I Class A Section 1(a) Betamethadol
UN: Narcotics Part 1 Section 1 Betamethadol
(15)
9611
Betaprodine
CA: CDSA Schedule I Section 3 Subsection 6 Betaprodine
UK: MDA Part I Class A Section 1(a) Betaprodine
UN: Narcotics Part 1 Section 1 Betaprodine
(16)
9612
Clonitazene
CA: CDSA Schedule I Section 13 Subsection 1 Clonitazene
UK: MDA Part I Class A Section 1(a) Clonitazene
UN: Narcotics Part 1 Section 1 Clonitazene
(17)
9613
Dextromoramide
CA: CDSA Schedule I Section 9 Subsection 1 Dextromoramide
UK: MDA Part I Class A Section 1(a) Dextromoramide
UN: Narcotics Part 1 Section 1 Dextromoramide
Effective 1 Oct 1976, 41 FR 43401 revoked (and renumbered subsequent entries):
Dextrorphan
(18)
9615
Diampromide
CA: CDSA Schedule I Section 12 Subsection 1 Diampromide
UK: MDA Part I Class A Section 1(a) Diampromide
UN: Narcotics Part 1 Section 1 Diampromide
(19)
9616
Diethylthiambutene
CA: CDSA Schedule I Section 8 Subsection 1 Diethylthiambutene
UK: MDA Part I Class A Section 1(a) Diethylthiambutene
UN: Narcotics Part 1 Section 1 Diethylthiambutene
Effective 1 Jun 1975, 40 FR 19813 added (and renumbered subsequent entries):
(20)
9168
(21)
9617
Dimenoxadol
CA: CDSA Schedule I Section 7 Subsection 1 Dimenoxadol
UK: MDA Part I Class A Section 1(a) Dimenoxadole
UN: Narcotics Part 1 Section 1 Dimenoxadol
(22)
9618
Dimepheptanol
CA: CDSA Schedule I Section 6 Subsection 6 Dimepheptanol
UK: MDA Part I Class A Section 1(a) Dimepheptanol
UN: Narcotics Part 1 Section 1 Dimepheptanol
(23)
9619
Dimethylthiambutene
CA: CDSA Schedule I Section 8 Subsection 2 Dimethylthiambutene
UK: MDA Part I Class A Section 1(a) Dimethylthiambutene
UN: Narcotics Part 1 Section 1 Dimethylthiambutene
(24)
9621
Dioxaphetyl butyrate
CA: CDSA Schedule I Section 7 Subsection 2 Dioxaphetyl butyrate
UK: MDA Part I Class A Section 1(a) Dioxaphetyl butyrate
UN: Narcotics Part 1 Section 1 Dioxaphetyl butyrate
(25)
9622
Dipipanone
CA: CDSA Schedule I Section 5 Subsection 2 Dipipanone
UK: MDA Part I Class A Section 1(a) Dipipanone
UN: Narcotics Part 1 Section 1 Dipipanone
(26)
9623
Ethylmethylthiambutene
CA: CDSA Schedule I Section 8 Subsection 3 Ethylmethylthiambutene
UK: MDA Part I Class A Section 1(a) Ethylmethylthiambutene
UN: Narcotics Part 1 Section 1 Ethylmethylthiambutene
(27)
9624
Etonitazene
CA: CDSA Schedule I Section 13 Subsection 2 Etonitazene
UK: MDA Part I Class A Section 1(a) Etonitazene
UN: Narcotics Part 1 Section 1 Etonitazene
(28)
9625
Etoxeridine
CA: CDSA Schedule I Section 3 Subsection 10 Etoxeridine
UK: MDA Part I Class A Section 1(a) Etoxeridine
UN: Narcotics Part 1 Section 1 Etoxeridine
(29)
9626
Furethidine
CA: CDSA Schedule I Section 3 Subsection 11 Furethidine
UK: MDA Part I Class A Section 1(a) Furethidine
UN: Narcotics Part 1 Section 1 Furethidine
(30)
9627
Hydroxypethidine
CA: CDSA Schedule I Section 3 Subsection 12 Hydroxypethidine
UK: [revoked] MDA Part I Class A Section 1(a) Hydroxypethidine
UN: Narcotics Part 1 Section 1 Hydroxypethidine
(31)
9628
Ketobemidone
CA: CDSA Schedule I Section 3 Subsection 13 Ketobemidone
UK: MDA Part I Class A Section 1(a) Ketobemidone
UN: Narcotics Part 1 Section 1 Ketobemidone and Section 3 Ketobemidone
(32)
9629
Levomoramide
CA: CDSA Schedule I Section 9 Subsection 3 Levomoramide
UK: MDA Part I Class A Section 1(a) Levomoramide
UN: Narcotics Part 1 Section 1 Levomoramide
(33)
9631
Levophenacylmorphan
CA: CDSA Schedule I Section 10 Subsection 5 Levophenacylmorphan
UK: MDA Part I Class A Section 1(a) Levophenacylmorphan
UN: Narcotics Part 1 Section 1 Levophenacylmorphan
Effective 22 Sep 1986, 51 FR 33592 added (and renumbered subsequent entries):
(34)
9813
3-Methylfentanyl (N-[3-Methyl-1-(2-phenylethyl)-4-piperidyl]-N-phenylpropanamide)
CA: CDSA Schedule I Section 16 Subsection 10 3-Methylfentanyl
UK: MDA Part I Class A Section 1(d) 3-Methylfentanyl
UN: Narcotics Part 1 Section 1 3-Methylfentanyl and Section 3 3-Methylfentanyl
Effective 29 May 1987, 52 FR 20070 added (and renumbered subsequent entries):
(35)
9833
3-Methylthiofentanyl (N-[3-Methyl-1-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide)
CA: CDSA Schedule I Section 16 Subsection 11 3-Methylthiofentanyl
UK: MDA Part I Class A Section 1(d) 3-Methylthiofentanyl
UN: Narcotics Part 1 Section 1 3-Methylthiofentanyl and Section 3 3-Methylthiofentanyl
(36)
9632
Morpheridine
CA: CDSA Schedule I Section 3 Subsection 15 Morpheridine
UK: MDA Part I Class A Section 1(a) Morpheridine
UN: Narcotics Part 1 Section 1 Morpheridine
(38)
9633
Noracymethadol
CA: CDSA Schedule I Section 6 Subsection 7 Noracymethadol
UK: MDA Part I Class A Section 1(a) Noracymethadol
UN: Narcotics Part 1 Section 1 Noracymethadol
(39)
9634
Norlevorphanol
CA: CDSA Schedule I Section 10 Subsection 6 Norlevorphanol
UK: MDA Part I Class A Section 1(a) Norlevorphanol
UN: Narcotics Part 1 Section 1 Norlevorphanol
(40)
9635
Normethadone
CA: CDSA Schedule I Section 5 Subsection 5 Normethadone
UK: MDA Part I Class A Section 1(a) Normethadone
UN: Narcotics Part 1 Section 1 Normethadone
(41)
9636
Norpipanone
CA: CDSA Schedule I Section 5 Subsection 6 Norpipanone
UK: MDA Part I Class A Section 1(a) Norpipanone
UN: Narcotics Part 1 Section 1 Norpipanone
Effective 29 May 1987, 52 FR 20070 added (and renumbered subsequent entries):
(42)
9812
Para-fluorofentanyl (N-(4-Fluorophenyl)-N-[1-(2-phenethyl)-4-piperidinyl]propanamide)
CA: CDSA Schedule I Section 16 Subsection 4 p-Fluorofentanyl
UK: MDA Part I Class A Section 1(d) p-Fluorofentanyl
UN: Narcotics Part 1 Section 1 Para-Fluorofentanyl and Section 3 Para-Fluorofentanyl
(44)
9637
Phenadoxone
CA: CDSA Schedule I Section 5 Subsection 7 Phenadoxone
UK: MDA Part I Class A Section 1(a) Phenadoxone
UN: Narcotics Part 1 Section 1 Phenadoxone
(45)
9638
Phenampromide
CA: CDSA Schedule I Section 12 Subsection 2 Phenampromide
UK: MDA Part I Class A Section 1(a) Phenampromide
UN: Narcotics Part 1 Section 1 Phenampromide
(46)
9647
Phenomorphan
CA: CDSA Schedule I Section 10 Subsection 7 Phenomorphan
UK: MDA Part I Class A Section 1(a) Phenomorphan
UN: Narcotics Part 1 Section 1 Phenomorphan
(47)
9641
Phenoperidine
CA: CDSA Schedule I Section 3 Subsection 18 Phenoperidine
UK: MDA Part I Class A Section 1(a) Phenoperidine
UN: Narcotics Part 1 Section 1 Phenoperidine
(48)
9642
Piritramide
CA: CDSA Schedule I Section 15 Piritramide
UK: MDA Part I Class A Section 1(a) Piritramide
UN: Narcotics Part 1 Section 1 Piritramide
(49)
9643
Proheptazine
CA: CDSA Schedule I Section 4 Subsection 1 Proheptazine
UK: MDA Part I Class A Section 1(a) Proheptazine
UN: Narcotics Part 1 Section 1 Proheptazine
(50)
9644
Properidine
CA: CDSA Schedule I Section 3 Subsection 20 Properidine
UK: MDA Part I Class A Section 1(a) Properidine
UN: Narcotics Part 1 Section 1 Properidine
(52)
9645
Racemoramide
CA: CDSA Schedule I Section 9 Subsection 4 Racemoramide
UK: MDA Part I Class A Section 1(a) Racemoramide
UN: Narcotics Part 1 Section 1 Racemoramide
Effective 25 May 1984, 49 FR 22074 revoked (and renumbered subsequent entries):
Effective 1 Dec 1980, 45 FR 64571 added:
9740
Sufentanil
US: Currently at CSA Schedule II Section c Subsection 27 Sufentanil
Effective 29 May 1987, 52 FR 20070 added (and renumbered subsequent entries):
(53)
9835
Thiofentanyl (N-Phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]propanamide)
CA: CDSA Schedule I Section 16 Subsection 13 Thiofentanyl
UK: MDA Part I Class A Section 1(d) Thiofentanyl
UN: Narcotics Part 1 Section 1 Thiofentanyl and Section 3 Thiofentanyl
(55)
9646
Trimeperidine
CA: CDSA Schedule I Section 3 Subsection 21 Trimeperidine
UK: MDA Part I Class A Section 1(a) Trimeperidine
UN: Narcotics Part 1 Section 1 Trimeperidine
(1)
9319
Acetorphine
CA: CDSA Schedule I Section 1 Subsection 5 Acetorphine
UK: MDA Part I Class A Section 1(a) Acetorphine
UN: Narcotics Part 1 Section 1 Acetorphine and Section 3 Acetorphine
(2)
9051
Acetyldihydrocodeine
CA: CDSA Schedule I Section 1 Subsection 6 Acetyldihydrocodeine
UK: MDA Part II Class B Section 1(a) Acetyldihydrocodeine
UN: Narcotics Part 1 Section 2 Acetyldihydrocodeine and Part 2 Section 1 Acetyldihydrocodeine
(3)
9052
Benzylmorphine
CA: CDSA Schedule I Section 1 Subsection 7 Benzylmorphine
UK: MDA Part I Class A Section 1(a) Benzylmorphine
UN: Narcotics Part 1 Section 1 Benzylmorphine
(7)
9055
Desomorphine
CA: CDSA Schedule I Section 1 Subsection 9 Desomorphine
UK: MDA Part I Class A Section 1(a) Desomorphine
UN: Narcotics Part 1 Section 1 Desomorphine and Section 3 Desomorphine
(8)
9145
Dihydromorphine
CA: CDSA Schedule I Section 1 Subsection 12 Dihydromorphine
UK: MDA Part I Class A Section 1(a) Dihydromorphine
UN: Narcotics Part 1 Section 1 Dihydromorphine
Effective 6 Aug 1973, 38 FR 17717 added:
(9)
9335
Drotebanol
CA: CDSA Schedule I Section 10 Subsection 2 Drotebanol
UK: MDA Part I Class A Section 1(a) Drotebanol
UN: Narcotics Part 1 Section 1 Drotebanol
(11)
9200
Heroin
CA: CDSA Schedule I Section 1 Subsection 10 Diacetylmorphine
UK: MDA Part I Class A Section 1(a) Diamorphine
(12)
9301
Hydromorphinol
CA: CDSA Schedule I Section 1 Subsection 16 Hydromorphinol
UK: MDA Part I Class A Section 1(a) Hydromorphinol
UN: Narcotics Part 1 Section 1 Hydromorphinol
(13)
9302
Methyldesorphine
CA: CDSA Schedule I Section 1 Subsection 18 Methyldesorphine
UK: MDA Part I Class A Section 1(a) Methyldesorphine
UN: Narcotics Part 1 Section 1 Methyldesorphine
(14)
9304
Methyldihydromorphine
CA: CDSA Schedule I Section 1 Subsection 19 Methyldihydromorphine
UK: MDA Part I Class A Section 1(a) Methyldihydromorphine
UN: Narcotics Part 1 Section 1 Methyldihydromorphine
(15)
9305
Morphine methobromide
UK: MDA Part I Class A Section 1(a) Morphine methobromide
UN: Narcotics Part 1 Section 1 Morphine methobromide
(17)
9307
Morphine-N-oxide
CA: CDSA Schedule I Section 1 Subsection 21 Morphine-N-oxide
UK: MDA Part I Class A Section 1(a) Morphine N-oxide
UN: Narcotics Part 1 Section 1 Morphine-N-oxide
(19)
9309
Nicocodeine
CA: CDSA Schedule I Section 1 Subsection 24 Nicocodine
UK: MDA Part II Class B Section 1(a) Nicocodine
UN: Narcotics Part 1 Section 2 Nicocodine and Part 2 Section 1 Nicocodine
(20)
9312
Nicomorphine
CA: CDSA Schedule I Section 1 Subsection 25 Nicomorphine
UK: MDA Part I Class A Section 1(a) Nicomorphine
UN: Narcotics Part 1 Section 1 Nicomorphine
(21)
9313
Normorphine
CA: CDSA Schedule I Section 1 Subsection 27 Normorphine
UK: MDA Part I Class A Section 1(a) Normorphine
UN: Narcotics Part 1 Section 1 Normorphine
(22)
9314
Pholcodine
CA: CDSA Schedule I Section 1 Subsection 30 Pholcodine
UK: MDA Part II Class B Section 1(a) Pholcodine
UN: Narcotics Part 1 Section 2 Pholcodine and Part 2 Section 1 Pholcodine
⇒
PubChem: 5311356; ChemSpider: 4470854; Bluelight: Pholcodine; Drugs Forum: Pholcodine; Wikipedia: Pholcodine
(d)
Hallucinogenic substances. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation, which contains any quantity of the following hallucinogenic substances, or which contains any of its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation (for purposes of this paragraph only, the term “isomer” includes the optical, position and geometric isomers):
Effective 12 Sep 1994, 59 FR 46757 added:
(1)
7249
Alpha-ethyltryptamine (Etryptamine; Monase; α-Ethyl-1H-indole-3-ethanamine; 3-(2-Aminobutyl)indole; α-ET; AET)
CA: CDSA Schedule III Section 28 Etryptamine
UK: MDA Part I Class A Section 1(a) Etryptamine
UN: Psychotropics Schedule I Etryptamine
Effective 21 Sep 1973, 38 FR 26447 added:
On 2 Jul 1973, 38 FR 17499 proposed to add:
(2)
7391
4-Bromo-2,5-dimethoxyamphetamine (4-Bromo-2,5-dimethoxy-α-methylphenethylamine; 4-Bromo-2,5-DMA)
CA: CDSA Schedule I Section 19 Subsection 14 4-Bromo-2,5-dimethoxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 15 4-Bromo-2,5-dimethoxyamphetamine
UK: MDA Part I Class A Section 1(a) 4-Bromo-2,5-dimethoxy-α-methylphenethylamine and Section 1(f) 4-Bromo-2,5-dimethoxy-α-methylphenethylamine
UN: Psychotropics Schedule I Brolamfetamine (DOB)
Effective 2 Jun 1995, 60 FR 28718 added:
On 20 Dec 1994, 59 FR 65521 proposed to add:
(3)
7392
4-Bromo-2,5-dimethoxyphenethylamine (2-(4-Bromo-2,5-dimethoxyphenyl)-1-aminoethane; Alpha-desmethyl DOB; 2C-B; Nexus)
CA: CDSA Schedule III Section 24 4-Bromo-2,5-dimethoxybenzeneethanamine
UK: MDA Part I Class A Section 1(c) 4-Bromo-2,5-dimethoxyphenethylamine
UN: Psychotropics Schedule II 2 C-B
Effective 21 Sep 1973, 38 FR 26447 added:
On 31 May 1973, 38 FR 14288 proposed to add:
(4)
7396
2,5-Dimethoxyamphetamine (2,5-Dimethoxy-α-methylphenethylamine; 2,5-DMA)
CA: CDSA Schedule I Section 19 Subsection 5 2,5-Dimethoxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 6 2,5-Dimethoxyamphetamine
UK: MDA Part I Class A Section 1(c) 2,5-Dimethoxyamphetamine
UN: Psychotropics Schedule I DMA
Effective 16 Feb 1993, 58 FR 4316 added:
(5)
7399
2,5-Dimethoxy-4-ethylamphetamine (DOET)
CA: CDSA Schedule I Section 19 Subsection 13 4-Ethyl-2,5-dimethoxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 14 4-Ethyl-2,5-dimethoxyamphetamine
UK: MDA Part I Class A Section 1(c) 4-Ethyl-2,5-dimethoxyamphetamine
UN: Psychotropics Schedule I DOET
⇒
PubChem: 27402; ChemSpider: 25499; PiHKAL • info: DOET; Wikipedia: 2,5-Dimethoxy-4-ethylamphetamine
Effective 18 Mar 2004, 69 FR 12794 added (and renumbered subsequent entries):
On 8 Sep 2003, 68 FR 52872 proposed to add (and to renumber subsequent entries):
(6)
7348
2,5-Dimethoxy-4-(n)-propylthiophenenthylamine (2C-T-7), its optical isomers, salts and salts of isomers
Effective 21 Sep 1973, 38 FR 26447 added:
On 2 Jul 1973, 38 FR 17499 proposed to add:
(7)
7411
4-Methoxyamphetamine (4-Methoxy-α-methylphenethylamine; Paramethoxyamphetamine; PMA)
CA: CDSA Schedule I Section 19 Subsection 6 4-Methoxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 7 4-Methoxyamphetamine
UK: MDA Part I Class A Section 1(c) 4-Methoxyamphetamine
UN: Psychotropics Schedule I PMA
(8)
7401
5-Methoxy-3,4-methylenedioxyamphetamine
CA: CDSA Schedule I Section 19 Subsection 10 5-Methoxy-3,4-methylenedioxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 11 5-Methoxy-3,4-methylenedioxyamphetamine
UK: MDA Part I Class A Section 1(c) 5-Methoxy-3,4-methylenedioxyamphetamine
UN: Psychotropics Schedule I MMDA
⇒
PubChem: 26175; ChemSpider: 24386; Drugs Forum: MMDA; PiHKAL • info: MMDA; Wikipedia: MMDA (psychedelic)
(9)
7395
4-Methyl-2,5-dimethoxyamphetamine (4-Methyl-2,5-dimethoxy-α-methylphenethylamine; DOM; STP)
CA: CDSA Schedule I Section 19 Subsection 3 4-Methyl-2,5-dimethoxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 4 4-Methyl-2,5-dimethoxyamphetamine
UK: MDA Part I Class A Section 1(a) 2,5-Dimethoxy-α,4-dimethylphenethylamine and Section 1(f) 2,5-Dimethoxy-α,4-dimethylphenethylamine
UN: Psychotropics Schedule I STP (DOM)
(10)
7400
3,4-Methylenedioxyamphetamine
CA: CDSA Schedule I Section 19 Subsection 4 3,4-Methylenedioxyamphetamine (MDA)
CA: [revoked] CDSA Schedule III Section 1 Subsection 5 3,4-Methylenedioxyamphetamine (MDA)
UK: MDA Part I Class A Section 1(c) 3,4-Methylenedioxyamphetamine
UN: Psychotropics Schedule I Tenamfetamine (MDA)
Effective 23 Mar 1988, 53 FR 5156 added:
Effective 27 Jan 1988, 53 FR 2225 revoked:
Effective 13 Nov 1986, 51 FR 36552 added (and renumbered subsequent entries):
(11)
7405
3,4-Methylenedioxymethamphetamine (MDMA)
[With thanks to Noel at NIH/NCGC for noticing this entry was botched.]
CA: CDSA Schedule I Section 19 Subsection 8 N-Methyl-3,4-methylenedioxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 9 N-Methyl-3,4-methylenedioxyamphetamine
UK: MDA Part I Class A Section 1(c) N-Methyl-3,4-methylenedioxyamphetamine
UN: Psychotropics Schedule I MDMA
Effective 13 Apr 1989, 54 FR 14797 added (and renumbered subsequent entries):
(12)
7404
3,4-Methylenedioxy-N-ethylamphetamine (N-Ethyl-alpha-methyl-3,4(methylenedioxy)phenethylamine; N-Ethyl MDA; MDE; MDEA)
CA: CDSA Schedule I Section 19 Subsection 12 N-Ethyl-3,4-methylenedioxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 13 N-Ethyl-3,4-methylenedioxyamphetamine
UK: MDA Part I Class A Section 1(c) N-Ethyl-3,4-methylenedioxyamphetamine
UN: Psychotropics Schedule I MDE (N-Ethyl MDA)
Effective 13 Apr 1989, 54 FR 14797 added (and renumbered subsequent entries):
(13)
7402
N-Hydroxy-3,4-methylenedioxyamphetamine (N-Hydroxy-alpha-methyl-3,4(methylenedioxy)phenethylamine; N-Hydroxy MDA)
CA: CDSA Schedule I Section 19 Subsection 20 N-Hydroxy-3,4-methylenedioxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 21 N-Hydroxy-3,4-methylenedioxyamphetamine
UK: MDA Part I Class A Section 1(a) N-Hydroxy-tenamphetamine and Section 1(f) N-Hydroxytenamphetamine
UN: Psychotropics Schedule I N-Hydroxy MDA
(14)
7390
3,4,5-Trimethoxyamphetamine
CA: CDSA Schedule I Section 19 Subsection 21 3,4,5-Trimethoxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 22 3,4,5-Trimethoxyamphetamine
UK: MDA Part I Class A Section 1(c) 3,4,5-Trimethoxyamphetamine
UN: Psychotropics Schedule I TMA
⇒
PubChem: 31016; ChemSpider: 28775; Bluelight: TMA and isomers; Drugs Forum: TMA 2; Erowid: TMA-2 (and other TMAs); PiHKAL • info: TMA; Wikipedia: Trimethoxyamphetamine
Effective 19 Jan 2011, 75 FR 79296 added (and renumbered subsequent entries):
Effective 28 Oct 2009, 74 FR 55502 extended the comment period of the earlier proposal to 27 Nov 2009 from 21 Sept 2009
On 21 Aug 2009, 74 FR 42217 proposed to add (and to renumber subsequent entries):
(15)
7431
5-Methoxy-N,N-dimethyltryptamine (5-Methoxy-3-[2-(dimethylamino)ethyl)]indole; 5-MeO-DMT), its isomers, salts and salts of isomers
On 1 Mar 2012, 77 FR 12508 proposed to add (and to renumber subsequent entries):
(18)
On 1 Mar 2012, 77 FR 12508 proposed to add:
(i)
1-Butyl-3-(1-naphthoyl)indole (JWH-073)
US: Currently at CSA Schedule I Section g Subsection 4 1-Butyl-3-(1-naphthoyl)indole
On 1 Mar 2012, 77 FR 12508 proposed to add:
(ii)
5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (CP 47,497)
US: Currently at CSA Schedule I Section g Subsection 1 5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol
On 1 Mar 2012, 77 FR 12508 proposed to add:
(iii)
5-(1,1-Dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (Cannabicyclohexanol; CP 47,497 C8 homologue)
US: Currently at CSA Schedule I Section g Subsection 2 5-(1,1-Dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol
On 1 Mar 2012, 77 FR 12508 proposed to add:
(iv)
1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole (JWH-200)
US: Currently at CSA Schedule I Section g Subsection 6 1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole
On 1 Mar 2012, 77 FR 12508 proposed to add:
(v)
1-Pentyl-3-(1-naphthoyl)indole (JWH-018; AM678)
US: Currently at CSA Schedule I Section g Subsection 3 1-Pentyl-3-(1-naphthoyl)indole
(18)
7434
Diethyltryptamine (N,N-Diethyltryptamine; DET)
CA: CDSA Schedule III Section 6 N,N-Diethyltryptamine
UK: MDA Part I Class A Section 1(a) N,N-Diethyltryptamine
UN: Psychotropics Schedule I DET
(19)
7435
Dimethyltryptamine (DMT)
CA: CDSA Schedule III Section 7 N,N-Dimethyltryptamine
UK: MDA Part I Class A Section 1(a) N,N-Dimethyltryptamine
UN: Psychotropics Schedule I DMT
Effective 29 Sep 2004, 69 FR 58050 added (and renumbered subsequent entries):
(20)
7439
5-Methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT), its isomers, salts and salts of isomers
UK: MDA Part I Class A Section 1(b) 5-Methoxy-N,N-diisopropyltryptamine
⇒
PubChem: 151182; ChemSpider: 133247; Bluelight: 5-MeO-DiPT; Drugs Forum: 5-MeO-DIPT; Erowid: 5-MeO-DIPT; TiHKAL • info: 5-MeO-DIPT; Wikipedia: 5-Methoxy-diisopropyltryptamine
(22)
7315
Lysergic acid diethylamide
CA: CDSA Schedule III Section 5 Lysergic acid diethylamide
UK: MDA Part I Class A Section 1(a) Lysergide
UN: Psychotropics Schedule I (+)-Lysergide (LSD) (LSD-25)
(26)
7415
Peyote
Meaning all parts of the plant presently classified botanically as Lophophora williamsii Lemaire, whether growing or not, the seeds thereof, any extract from any part of such plant, and every compound, manufacture, salts, derivative, mixture, or preparation of such plant, its seeds or extracts (Interprets 21 USC 812(c), Schedule I(c) (12))
CA: [not controlled] CDSA Schedule III Section 17 Lophophora
⇒
PubChem: 135309929 135330128; Bluelight: Peyote; Drugs Forum: Peyote; Erowid: Peyote; Wikipedia: Peyote
(28)
7484
N-Methyl-3-piperidyl benzilate
CA: CDSA Schedule III Section 8 N-Methyl-3-piperidyl benzilate (LBJ)
(29)
7437
Psilocybin
CA: CDSA Schedule III Section 12 Psilocybin
UK: MDA Part I Class A Section 1(b) Psilocybin
UN: Psychotropics Schedule I Psilocybine
⇒
PubChem: 10624; ChemSpider: 10178; Drugs Forum: 4-H2PO4-DMT; Erowid: Psilocybin & Psilocin; TiHKAL • info: 4-H2PO4-DMT; Wikipedia: Psilocybin
(30)
7438
Psilocyn [sic]
This substance is more commonly spelled Psilocin.
CA: CDSA Schedule III Section 11 Psilocin
UK: MDA Part I Class A Section 1(a) Psilocin
UN: Psychotropics Schedule I Psilocine (Psilotsin)
On 8 Sep 2003, 68 FR 52872 proposed to add (and to renumber subsequent entries):
7494
1-(3-Trifluoromethylphenyl)piperazine (TFMPP)
The proposal to schedule TFMPP was never acted upon. So, once the extended emergency scheduling enacted by 67 FR 59163 expired on 19 Mar 2004, TFMPP was no longer a scheduled substance.
CA: CDSA Schedule III Section 34 Trifluoromethylphenylpiperazine
⇒
PubChem: 4296; ChemSpider: 4145; Bluelight: BZP + TFMPP; Drugs Forum: TFMPP; Erowid: TFMPP; Wikipedia: Trifluoromethylphenylpiperazine
Δ1 cis or trans Tetrahydrocannabinol
Δ6 cis or trans Tetrahydrocannabinol
Δ3,4 cis or trans Tetrahydrocannabinol
(31)
7370
Tetrahydrocannabinols
Meaning Tetrahydrocannabinols naturally contained in a plant of the genus Cannabis (cannabis plant), as well as synthetic equivalents of the substances contained in the cannabis plant, or in the resinous extractives of such plant, and/or synthetic substances, derivatives, and their isomers with similar chemical structure and pharmacological activity to those substances contained in the plant, such as the following:
Meaning Tetrahydrocannabinols naturally contained in a plant of the genus Cannabis (cannabis plant), as well as synthetic equivalents of the substances contained in the cannabis plant, or in the resinous extractives of such plant, and/or synthetic substances, derivatives, and their isomers with similar chemical structure and pharmacological activity to those substances contained in the plant, such as the following:
- Δ1 cis or trans Tetrahydrocannabinol, and their optical isomers
- Δ6 cis or trans Tetrahydrocannabinol, and their optical isomers
- Δ3,4 cis or trans Tetrahydrocannabinol, and its optical isomers
(Since nomenclature of these substances is not internationally standardized, compounds of these structures, regardless of numerical designation of atomic positions covered.)
CA: CDSA Schedule II Section 1 Subsection 7 Tetrahydrocannabinol
UK: MDA Part II Class B Section 1(a) Tetrahydrocannabinol
⇒
PubChem: 16078; ChemSpider: 4479482; Bluelight: Tetrahydrocannabinol; Erowid: Cannabis; Wikipedia: TetrahydrocannabinolUN: Psychotropics Schedule I (6aR,10aR)-6a,7,10,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol
UN: Psychotropics Schedule I 7,8,9,10-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol
Effective 25 Oct 1978, 43 FR 43295 added:
(32)
7455
Ethylamine analog of Phencyclidine (N-Ethyl-1-phenylcyclohexylamine; (1-Phenylcyclohexyl)ethylamine; N-(1-Phenylcyclohexyl)ethylamine; Cyclohexamine; PCE)
CA: CDSA Schedule III Section 13 N-(1-Phenylcyclohexyl)ethylamine
UK: MDA Part I Class A Section 1(a) Eticyclidine
UN: Psychotropics Schedule I Eticyclidine (PCE)
Effective 25 Oct 1978, 43 FR 43295 added:
(33)
7458
Pyrrolidine analog of Phencyclidine (1-(1-Phenylcyclohexyl)pyrrolidine; PCPy; PHP)
[With thanks to Noel at NIH/NCGC for noticing this entry was botched.]
CA: CDSA Schedule III Section 16 Rolicyclidine
UK: MDA Part I Class A Section 1(a) Rolicyclidine
UN: Psychotropics Schedule I Rolicyclidine (PHP) (PCPY)
⇒
PubChem: 62436; ChemSpider: 56218; Bluelight: PCP analogs; Drugs Forum: PCP analogs; Erowid: Rolicyclidine synthesis; Wikipedia: Rolicyclidine
Effective 11 Aug 1975, 40 FR 28611b added (and renumbered subsequent entries):
On 29 May 1975, 40 FR 23306 proposed to add (and to renumber subsequent entries):
(34)
7470
Thiophene analog of Phencyclidine (1-[1-(2-Thienyl)cyclohexyl]piperidine; 2-Thienyl analog of Phencyclidine; TPCP; TCP)
CA: CDSA Schedule III Section 14 1-[1-(2-Thienyl)cyclohexyl]piperidine
UK: MDA Part I Class A Section 1(a) Tenocyclidine
UN: Psychotropics Schedule I Tenocyclidine (TCP)
⇒
PubChem: 62751; ChemSpider: 56495; Bluelight: PCP analogs; Drugs Forum: Tenocyclidine; Wikipedia: Tenocyclidine![3D rendering of 1-[1-(2-Thienyl)cyclohexyl]pyrrolidine](data:image/png;base64,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 "Click for a 3D rendering of 1-[1-(2-Thienyl)cyclohexyl]pyrrolidine")
On 5 Jul 2011, 76 FR 39039 proposed to add:
(36)
7350
Marihuana extract
UN: Narcotics Part 1 Section 1 Extracts and tinctures of cannabis
Effective 4 Jan 2013, 78 FR 664 finalized the prior interim scheduling:
Effective 9 Jul 2012, S. 3187, 112 Cong., 2nd Sess. added:
(36)
1248
4-Methylmethcathinone (Mephedrone)
EU: Substances Substances 4-Methylmethcathinone
UK: MDA Part II Class B Section 1(aa) 4-Methylmethcathinone; Mephedrone
⇒
PubChem: 45266826; ChemSpider: 21485694; Bluelight: Mephedrone; Drugs Forum: Mephedrone; Erowid: 4-Methylmethcathinone / Mephedrone; Wikipedia: Mephedrone
Effective 4 Jan 2013, 78 FR 664 finalized the prior interim scheduling:
Effective 9 Jul 2012, S. 3187, 112 Cong., 2nd Sess. added:
(37)
7535
3,4-Methylenedioxypyrovalerone (MDPV)
CA: CDSA Schedule I Section 17.1 Methylenedioxypyrovalerone
EU: Substances Substances 3,4-Methylenedioxypyrovalerone
UK: MDA Part II Class B Section 1(aa) MDPV
Effective 4 Jan 2013, 78 FR 664 finalized the prior interim scheduling:
Effective 9 Jul 2012, S. 3187, 112 Cong., 2nd Sess. added:
(38)
7509
Effective 4 Jan 2013, 78 FR 664 finalized the prior interim scheduling:
Effective 9 Jul 2012, S. 3187, 112 Cong., 2nd Sess. added:
(39)
7508
Effective 4 Jan 2013, 78 FR 664 finalized the prior interim scheduling:
Effective 9 Jul 2012, S. 3187, 112 Cong., 2nd Sess. added:
(40)
7519
Effective 4 Jan 2013, 78 FR 664 finalized the prior interim scheduling:
Effective 9 Jul 2012, S. 3187, 112 Cong., 2nd Sess. added:
(41)
7518
![3D rendering of 2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine](data:image/png;base64,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 "Click for a 3D rendering of 2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine")
Effective 4 Jan 2013, 78 FR 664 finalized the prior interim scheduling:
Effective 9 Jul 2012, S. 3187, 112 Cong., 2nd Sess. added:
(42)
7585
![3D rendering of 2-[4-(Isopropylthio)-2,5-dimethoxy-phenyl]ethylamine](data:image/png;base64,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 "Click for a 3D rendering of 2-[4-(Isopropylthio)-2,5-dimethoxy-phenyl]ethylamine")
Effective 4 Jan 2013, 78 FR 664 finalized the prior interim scheduling:
Effective 9 Jul 2012, S. 3187, 112 Cong., 2nd Sess. added:
(43)
7532
2-[4-(Isopropylthio)-2,5-dimethoxy-phenyl]ethylamine (2C-T-4)
UK: MDA Part I Class A Section 1(c) 4-Isopropylthio-2,5-dimethoxyphenethylamine and 4-Isopropylthio-2,5-dimethoxyphenethylamine
Effective 4 Jan 2013, 78 FR 664 finalized the prior interim scheduling:
Effective 9 Jul 2012, S. 3187, 112 Cong., 2nd Sess. added:
(44)
7517
2-(2,5-Dimethoxyphenyl)ethanamine (2C-H)
UK: MDA Part I Class A Section 1(c) 2,5-Dimethoxyphenethylamine
Effective 4 Jan 2013, 78 FR 664 finalized the prior interim scheduling:
Effective 9 Jul 2012, S. 3187, 112 Cong., 2nd Sess. added:
(46)
7524
Effective 12 Apr 2013, 78 FR 21818 added:
On 17 Oct 2012, 77 FR 63766 proposed to add:
(47)
7540
3,4-Methylenedioxy-N-methylcathinone (Methylone)
In the few months between the proposed and final ruling this section of the schedule has grown by 28 per cent.
On 13 Nov 2015, 80 FR 70649 proposed to add:
(48)
7538
2-(4-Iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25I-NBOMe; 2C-I-NBOMe)
EU: Substances Substances 2-(4-Iodo-2,5-dimethoxy)-N-(2-methoxybenzyl) phenethylamine
UK: MDA Part I Class A Section 1(f) 2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
UK: [revoked] MDA Temporary Class Drug Orders 2013 2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
See also CSA Schedule I Section h Subsection 4 2-(4-Iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
On 13 Nov 2015, 80 FR 70649 proposed to add:
(49)
7537
2-(4-Chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25C-NBOMe; 2C-C-NBOMe)
UK: MDA Part I Class A Section 1(f) 2-(4-Chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
UK: [revoked] MDA Temporary Class Drug Orders 2013 2-(4-Chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
See also CSA Schedule I Section h Subsection 5 2-(4-Chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
On 13 Nov 2015, 80 FR 70649 proposed to add:
(50)
7536
2-(4-Bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25B-NBOMe; 2C-B-NBOMe)
UK: MDA Part I Class A Section 1(f) 2-(4-Bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
UK: [revoked] MDA Temporary Class Drug Orders 2013 2-(4-Bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
See also CSA Schedule I Section h Subsection 6 2-(4-Bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
(e)
Depressants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:
Effective 13 Mar 2000, 65 FR 13235 added:
(1)
2010
Gamma-hydroxybutyric acid (GHB; Gamma-hydroxybutyrate; 4-Hydroxybutyrate; 4-Hydroxybutanoic acid; Sodium oxybate; Sodium oxybutyrate)
CA: CDSA Schedule I Section 21 4-Hydroxybutanoic acid
CA: [revoked] CDSA Schedule III Section 26 4-Hydroxybutanoic acid
UK: MDA Part III Class C Section 1(a) 4-Hydroxy-n-butyric acid
UN: Psychotropics Schedule II GHB
UN: [revoked] Psychotropics Schedule IV GHB
See also CSA Schedule III Section c Subsection 6 Gamma-hydroxybutyric acid
⇒
PubChem: 10413; ChemSpider: 9984; Drugs Forum: GHB; Erowid: GHB; Wikipedia: gamma-Hydroxybutyric acid
Effective 10 Jul 1975, 40 FR 28611a added:
On 29 May 1975, 40 FR 23306 proposed to add:
(2)
2572
Mecloqualone
CA: CDSA Schedule III Section 4 Mecloqualone
UK: MDA Part II Class B Section 1(a) Mecloqualone
UN: Psychotropics Schedule II Mecloqualone
Effective 27 Aug 1984, 49 FR 33870 added:
(3)
2565
Methaqualone
CA: CDSA Schedule III Section 3 Methaqualone
UK: MDA Part II Class B Section 1(a) Methaqualone
UN: Psychotropics Schedule II Methaqualone
⇒
PubChem: 6292; ChemSpider: 6055; Bluelight: Methaqualone; Drugs Forum: Methaqualone; Erowid: Methaqualone; Wikipedia: MethaqualoneEffective 20 Aug 1981, 46 FR 37503 added:
(f)
Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers:
Effective 18 Mar 1994, 59 FR 12828 added (and renumbered subsequent entries):
(1)
1585
Aminorex (Aminoxaphen; 2-Amino-5-phenyl-2-oxazoline; 4,5-Dihydro-5-phenyl-2-oxazolamine)
Effective 6 Aug 2010, 75 FR 47503 corrected the claim made in 68 FR 52872 that BZP is 10 to 20 times more potent than amphetamine. Instead, the converse is now claimed: that BZP is 10 to 20 times less potent than amphetamine.
Effective 6 Aug 2010, 75 FR 47451 corrected the claim made in 68 FR 12794 that BZP is 10 to 20 times more potent than amphetamine. Instead, the converse is now claimed: that BZP is 10 to 20 times less potent than amphetamine.
Effective 18 Mar 2004, 69 FR 12794 added (and renumbered subsequent entries):
On 8 Sep 2003, 68 FR 52872 proposed to add (and to renumber subsequent entries):
(2)
7493
N-Benzylpiperazine (BZP; 1-Benzylpiperazine), its optical isomers, salts and salts of isomers
CA: CDSA Schedule III Section 33 Benzylpiperazine
EU: Substances Substances 1-Benzylpiperazine
UK: MDA Part III Class C Section 1(ca) 1-Benzylpiperazine
Effective 16 Feb 1993, 58 FR 4316 added:
(3)
1235
Cathinone (2-Amino-1-phenyl-1-propanone; Alpha-aminopropiophenone; 2-Aminopropiophenone; Norephedrone)
Effective 20 Aug 1981, 46 FR 37503 added:
(4)
1503
Fenethylline
CA: CDSA Schedule III Section 20 Fenetylline
UK: MDA Part III Class C Section 1(a) Fenethylline
UN: Psychotropics Schedule II Fenetylline
Effective 15 Oct 1993, 58 FR 53404 added (and renumbered subsequent entries):
(5)
1237
Methcathinone (2-(Methylamino)propiophenone; Alpha-(methylamino)propiophenone; 2-(Methylamino)-1-phenylpropan-1-one; Alpha-N-methylaminopropiophenone; Monomethylpropion; Ephedrone; N-Methylcathinone; Methylcathinone; AL-464; AL-422; AL-463; UR1432), its salts, optical isomers and salts of optical isomers
CA: CDSA Schedule III Section 21 2-Methylamino-1-phenyl-1-propanone
UK: MDA Part II Class B Section 1(a) Methcathinone
UN: Psychotropics Schedule I Methcathinone
⇒
PubChem: 1576; ChemSpider: 1519; Bluelight: methcathinone; Drugs Forum: methcathinone; Erowid: Cathinone and methcathinone; Wikipedia: Methcathinone
Effective 13 Apr 1989, 54 FR 14799 added (and renumbered subsequent entries):
(6)
1590
(±)-cis-4-Methylaminorex ((±)-cis-4,5-Dihydro-4-methyl-5-phenyl-2-oxazolamine)
CA: CDSA Schedule III Section 18 4-Methylaminorex
UK: MDA Part I Class A Section 1(a) 4-Methyl-aminorex
UN: Psychotropics Schedule I 4-Methylaminorex
⇒
PubChem: 92196; ChemSpider: 83237; Drugs Forum: 4-MAR; Erowid: 4-Methyl-aminorex; Wikipedia: 4-Methylaminorex
(7)
1475
N-Ethylamphetamine
CA: CDSA Schedule I Section 19 Subsection 2 N-Ethylamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 3 N-Ethylamphetamine
UK: MDA Part III Class C Section 1(a) N-Ethylamphetamine
UN: Psychotropics Schedule IV Etilamfetamine (N-Ethylamphetamine)
Effective 2 Feb 1990, 55 FR 3586 added (and renumbered subsequent entries):
(8)
1480
N,N-Dimethylamphetamine (N,N-Alpha-trimethyl-benzeneethanamine; N,N-Alpha-trimethylphenethylamine)
Effective 4 Jan 2013, 78 FR 664 finalized the prior interim scheduling:
Effective 9 Jul 2012, S. 3187, 112 Cong., 2nd Sess. added:
(g)
Cannabimimetic Agents. Unless specifically exempted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of cannabimimetic agents, or which contains their salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation.
Effective 9 Jul 2012, S. 3187, 112 Cong., 2nd Sess. added:
(A)
The term ‘cannabimimetic agents’ means any substance that is a cannabinoid receptor type 1 (CB1 receptor) agonist as demonstrated by binding studies and functional assays within any of the following structural classes:
Effective 9 Jul 2012, S. 3187, 112 Cong., 2nd Sess. added:
(i)
2-(3-Hydroxycyclohexyl)phenol with substitution at the 5-position of the phenolic ring by alkyl or alkenyl, whether or not substituted on the cyclohexyl ring to any extent.
UK: MDA Part II Class B Section 1(c) 2-(3-Hydroxycyclohexyl)phenol
3-(1-Naphthoyl)indole
3-(1-Naphthylmethane)indole
Effective 9 Jul 2012, S. 3187, 112 Cong., 2nd Sess. added:
(ii)
3-(1-Naphthoyl)indole or 3-(1-Naphthylmethane)indole by substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent, whether or not substituted on the naphthoyl or naphthyl ring to any extent.
CA: CDSA Schedule II Section 2 Subsection 2 3-(1-Naphthoyl)indole
UK: MDA Part II Class B Section 1(c) 3-(1-Naphthoyl)indole
UK: MDA Part II Class B Section 1(c) 1H-Indol-3-yl-(1-naphthyl)methane
Effective 9 Jul 2012, S. 3187, 112 Cong., 2nd Sess. added:
(iii)
3-(1-Naphthoyl)pyrrole by substitution at the nitrogen atom of the pyrrole ring, whether or not further substituted in the pyrrole ring to any extent, whether or not substituted on the naphthoyl ring to any extent.
CA: CDSA Schedule II Section 2 Subsection 3 3-(1-Naphthoyl)pyrrole
UK: MDA Part II Class B Section 1(c) 3-(1-Naphthoyl)pyrrole
Effective 9 Jul 2012, S. 3187, 112 Cong., 2nd Sess. added:
(iv)
1-(1-Naphthylmethylene)indene by substitution of the 3-position of the indene ring, whether or not further substituted in the indene ring to any extent, whether or not substituted on the naphthyl ring to any extent.
UK: MDA Part II Class B Section 1(c) 1-(1-Naphthylmethylene)indene
3-Phenylacetylindole
3-Benzoylindole
Effective 9 Jul 2012, S. 3187, 112 Cong., 2nd Sess. added:
(v)
3-Phenylacetylindole or 3-Benzoylindole by substitution at the nitrogen atom of the indole ring, whether or not further substituted in the indole ring to any extent, whether or not substituted on the phenyl ring to any extent.
CA: CDSA Schedule II Section 2 Subsection 4 3-Phenylacetylindole
UK: MDA Part II Class B Section 1(c) 3-Phenylacetylindole
CA: CDSA Schedule II Section 2 Subsection 5 3-Benzoylindole
UK: MDA Part II Class B Section 1(c) 3-Benzoylindole
![3D rendering of 5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol](data:image/png;base64,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 "Click for a 3D rendering of 5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol")
Effective 4 Jan 2013, 78 FR 664 finalized the prior interim scheduling:
Effective 9 Jul 2012, S. 3187, 112 Cong., 2nd Sess. added:
(1)
7297
5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (CP 47,497)
CA: CDSA Schedule II Section 2 Subsection 1 5-(1,1-Dimethylheptyl)-2-(3-hydroxycyclohexyl)phenol
UK: MDA Part II Class B Section 1(c) CP 47,497
⇒
PubChem: 15942731; ChemSpider: 10205286; Drugs Forum: CP 47,497; Erowid: Spice Product; Wikipedia: CP 47,497![3D rendering of 5-(1,1-Dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol](data:image/png;base64,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 "Click for a 3D rendering of 5-(1,1-Dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol")
Effective 4 Jan 2013, 78 FR 664 finalized the prior interim scheduling:
Effective 9 Jul 2012, S. 3187, 112 Cong., 2nd Sess. added:
(2)
7298
5-(1,1-Dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (Cannabicyclohexanol; CP 47,497 C8 homologue)
UK: MDA Part II Class B Section 1(c) CP 47,497-C8
Effective 4 Jan 2013, 78 FR 664 finalized the prior interim scheduling:
Effective 9 Jul 2012, S. 3187, 112 Cong., 2nd Sess. added:
(3)
7118
1-Pentyl-3-(1-naphthoyl)indole (JWH-018; AM678)
CA: CDSA Schedule II Section 2 Subsection 2 1-Pentyl-3-(1-naphthoyl)indole
UK: MDA Part II Class B Section 1(c) JWH-018
Effective 4 Jan 2013, 78 FR 664 finalized the prior interim scheduling:
Effective 9 Jul 2012, S. 3187, 112 Cong., 2nd Sess. added:
(4)
7173
1-Butyl-3-(1-naphthoyl)indole (JWH-073)
CA: CDSA Schedule II Section 2 Subsection 2 1-Butyl-3-(1-naphthoyl)indole
UK: MDA Part II Class B Section 1(c) JWH-073
⇒
PubChem: 10471670; ChemSpider: 8647081; Bluelight: JWH-073; Erowid: Spice Product; Wikipedia: JWH-073
Effective 4 Jan 2013, 78 FR 664 finalized the prior interim scheduling:
Effective 9 Jul 2012, S. 3187, 112 Cong., 2nd Sess. added:
(5)
7019
1-Hexyl-3-(1-naphthoyl)indole (JWH-019)
CA: CDSA Schedule II Section 2 Subsection 2 1-Hexyl-3-(1-naphthoyl)indole
![3D rendering of 1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole](data:image/png;base64,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 "Click for a 3D rendering of 1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole")
Effective 4 Jan 2013, 78 FR 664 finalized the prior interim scheduling:
Effective 9 Jul 2012, S. 3187, 112 Cong., 2nd Sess. added:
(6)
7200
1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole (JWH-200)
CA: CDSA Schedule II Section 2 Subsection 2 1-(2-Morpholin-4-ylethyl)-3-(1naphthoyl)indole
UK: MDA Part II Class B Section 1(c) JWH-200
⇒
PubChem: 10045570; ChemSpider: 8221134; Drugs Forum: JWH-200; Erowid: Spice Product; Wikipedia: JWH-200
Effective 4 Jan 2013, 78 FR 664 finalized the prior interim scheduling:
Effective 9 Jul 2012, S. 3187, 112 Cong., 2nd Sess. added:
(7)
6250
![3D rendering of 1-Pentyl-3-[1-(4-methoxynaphthoyl)]indole](data:image/png;base64,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 "Click for a 3D rendering of 1-Pentyl-3-[1-(4-methoxynaphthoyl)]indole")
Effective 4 Jan 2013, 78 FR 664 finalized the prior interim scheduling:
Effective 9 Jul 2012, S. 3187, 112 Cong., 2nd Sess. added:
(8)
7081
1-Pentyl-3-[1-(4-methoxynaphthoyl)]indole (JWH-081)
CA: CDSA Schedule II Section 2 Subsection 2 1-Butyl-3-(4-methoxy-1-naphthoyl)indole
UK: MDA Part II Class B Section 1(c) JWH-081
Effective 4 Jan 2013, 78 FR 664 finalized the prior interim scheduling:
Effective 9 Jul 2012, S. 3187, 112 Cong., 2nd Sess. added:
(9)
7122
Effective 4 Jan 2013, 78 FR 664 finalized the prior interim scheduling:
Effective 9 Jul 2012, S. 3187, 112 Cong., 2nd Sess. added:
(10)
7398
Effective 4 Jan 2013, 78 FR 664 finalized the prior interim scheduling:
Effective 9 Jul 2012, S. 3187, 112 Cong., 2nd Sess. added:
(11)
7201
Effective 4 Jan 2013, 78 FR 664 finalized the prior interim scheduling:
Effective 9 Jul 2012, S. 3187, 112 Cong., 2nd Sess. added:
(12)
7694
![3D rendering of 1-Pentyl-3-[(4-methoxy)-benzoyl]indole](data:image/png;base64,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 "Click for a 3D rendering of 1-Pentyl-3-[(4-methoxy)-benzoyl]indole")
Effective 4 Jan 2013, 78 FR 664 finalized the prior interim scheduling:
Effective 9 Jul 2012, S. 3187, 112 Cong., 2nd Sess. added:
(13)
7104
Effective 4 Jan 2013, 78 FR 664 finalized the prior interim scheduling:
Effective 9 Jul 2012, S. 3187, 112 Cong., 2nd Sess. added:
(14)
7008
Effective 4 Jan 2013, 78 FR 664 finalized the prior interim scheduling:
Effective 9 Jul 2012, S. 3187, 112 Cong., 2nd Sess. added:
(15)
7203
On 14 May 2015, 80 FR 27611 proposed to add:
(16)
7144
(1-Pentyl-1H-indol-3-yl)(2,2,3,3-
tetramethylcyclopropyl)methanone (UR-144)
CA: CDSA Schedule II Section 2 Subsection 6 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-
tetramethylcyclopropyl)-methanone
UK: MDA Part II Class B Section 1(c) UR-144
See also CSA Schedule I Section h Subsection 1 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-
tetramethylcyclopropyl)methanone
methanone](data:image/png;base64,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 "Click for a 3D rendering of [1-(5-Fluoro-pentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone")
On 14 May 2015, 80 FR 27611 proposed to add:
(17)
7011
[1-(5-Fluoro-pentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone (5-Fluoro-UR-144; XLR11)
CA: CDSA Schedule II Section 2 Subsection 6 [1-(5-Fluoro-pentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)-methanone
UK: MDA Part II Class B Section 1(c) XLR11
See also CSA Schedule I Section h Subsection 2 [1-(5-Fluoro-pentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone
On 14 May 2015, 80 FR 27611 proposed to add:
(18)
7048
N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide (APINACA; AKB48)
CA: CDSA Schedule II Section 2 Subsection 8 N-(Adamantan-1-yl)-1-pentyl-1H-indazole-3-carboxamide
See also CSA Schedule I Section h Subsection 3 N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide
⇒
PubChem: 57404063; ChemSpider: 28189076; Bluelight: AKB48; Drugs Forum: AKB48; Wikipedia: AKB48 (drug)Effective 4 Jan 2013, 78 FR 664 renumbered:
Effective 25 Apr 1985, 50 FR 11690 added:
(h)
Temporary listing of substances subject to emergency scheduling. Any material, compound, mixture or preparation which contains any quantity of the following substances:
Effective 22 Sep 1986, 51 FR 33592 revoked (and renumbered subsequent entries):
Effective 25 Apr 1986, 51 FR 15474 extended, for six months’ duration, the prior emergency scheduling:
Effective 25 Apr 1985, 50 FR 11690 added, for one years’ duration, via the emergency scheduling provision of 21 USC 811(h):
N-[3-Methyl-1-(2-phenylethyl)-4-piperidyl]-N-phenylpropanamide (3-Methylfentanyl) its optical and geometric isomers, salts and salts of isomers
US: Currently at CSA Schedule I Section b Subsection 34 3-Methylfentanyl
Effective 13 Nov 1986, 51 FR 36552 revoked (and renumbered subsequent entries):
Effective 1 Jul 1986, 51 FR 21911 extended, for six months’ duration, the prior emergency scheduling:
Effective 1 Jul 1985, 50 FR 23118 added, for one years’ duration, via the emergency scheduling provision of 21 USC 811(h):
3,4-Methylenedioxymethamphetamine (MDMA), its optical, positional and geometric isomers, salts and salts of isomers
US: Currently at CSA Schedule I Section d Subsection 11 3,4-Methylenedioxymethamphetamine
Effective 23 Jan 1987, 52 FR 2515 revoked (and renumbered subsequent entries):
Effective 12 Aug 1986, 51 FR 28695 extended, for six months’ duration, the prior emergency scheduling:
Effective 12 Aug 1985, 50 FR 28098 added, for one years’ duration, via the emergency scheduling provision of 21 USC 811(h):
1-Methyl-4-phenyl-4-propionoxypiperidine (MPPP), its optical isomers, salts and salts of isomers
US: Currently at CSA Schedule I Section b Subsection 37 MPPP
Effective 23 Jan 1987, 52 FR 2515 revoked (and renumbered subsequent entries):
Effective 12 Aug 1986, 51 FR 28695 extended, for six months’ duration, the prior emergency scheduling:
Effective 12 Aug 1985, 50 FR 28098 added, for one years’ duration, via the emergency scheduling provision of 21 USC 811(h):
1-(2-Phenethyl)-4-phenyl-4-acetoxypiperidine (PEPAP), its optical isomers, salts and salts of isomers
US: Currently at CSA Schedule I Section b Subsection 43 PEPAP
Effective 29 May 1987, 52 FR 20070 revoked (and renumbered subsequent entries):
Effective 29 Nov 1986, 51 FR 42834 extended, for six months’ duration, the prior emergency scheduling:
Effective 29 Nov 1985, 50 FR 43698 added, for one years’ duration, via the emergency scheduling provision of 21 USC 811(h):
N-[1-(1-Methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide (Acetyl-alpha-methylfentanyl), its optical isomers, salts and salts of isomers
US: Currently at CSA Schedule I Section b Subsection 1 Acetyl-alpha-methylfentanyl
Effective 29 May 1987, 52 FR 20070 revoked (and renumbered subsequent entries):
Effective 29 Nov 1986, 51 FR 42834 extended, for six months’ duration, the prior emergency scheduling:
Effective 29 Nov 1985, 50 FR 43698 added, for one years’ duration, via the emergency scheduling provision of 21 USC 811(h):
N-[1-Methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide (Alpha-methylthiofentanyl), its optical isomers, salts and salts of isomers
US: Currently at CSA Schedule I Section b Subsection 8 Alpha-methylthiofentanyl
Effective 4 Jan 2013, 78 FR 664 revoked:
Effective 29 Feb 2012, 77 FR 12201 extended, for six months’ duration, the prior emergency scheduling:
5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (CP 47,497), its optical, positional, and geometric isomers, salts and salts of isomers
Effective 1 Mar 2011, 76 FR 11075 replacement, for one year’s duration, via the emergency scheduling provision of 21 USC 811(h), for:
On 24 Nov 2010, 75 FR 71635 proposed replacement, for one year’s duration, via the emergency scheduling provision of 21 USC 811(h), for:
[Reserved]
Effective 29 Jun 2010, 75 FR 37300 replacement for:
Effective 29 May 1987, 52 FR 20070 renumbered:
Effective 29 Nov 1985, 50 FR 43698 added, for one years’ duration, via the emergency scheduling provision of 21 USC 811(h):
N-[1-Benzyl-4-piperidyl]-N-phenylpropanamide (Benzylfentanyl) its optical and geometric isomers, salts and salts of isomers
This substance remained “scheduled” even though the legal authorization that placed it here (50 FR 43698) had expired decades earlier. After a quarter of a century, 75 FR 37300 ultimately banishes it.
Effective 13 Jan 2011, 76 FR 2287 corrected the prior notice of proposed scheduling, 75 FR 71635, by striking out parts addressing the Regulatory Flexibility Act and the Congressional Review Act on the grounds that neither Act applies to the proposal and are therefore immaterial.
While 75 FR 71635 proposed to add only five substances to Schedule I, final rule 76 FR 11075 casts the net rather wider, scheduling the original five and “…the optical, positional, and geometric isomers, salts and salts of isomers” of each. The final rule is silent about this incongruity.
US: Currently at CSA Schedule I Section g Subsection 1 5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol
Effective 29 May 1987, 52 FR 20070 revoked (and renumbered subsequent entries):
Effective 29 Nov 1986, 51 FR 42834 extended, for six months’ duration, the prior emergency scheduling:
Effective 29 Nov 1985, 50 FR 43698 added, for one years’ duration, via the emergency scheduling provision of 21 USC 811(h):
N-[1-(2-Hydroxy-2-phenethyl)-4-piperidinyl]-N-phenylpropanamide (Beta-hydroxyfentanyl), its optical isomers, salts and salts of isomers
US: Currently at CSA Schedule I Section b Subsection 11 Beta-hydroxyfentanyl
Effective 8 Jan 1988, 53 FR 500 revoked (and renumbered subsequent entries):
Effective 29 Nov 1986, 51 FR 42834 extended, for six months’ duration, the prior emergency scheduling:
Effective 29 Nov 1985, 50 FR 43698 added, for one years’ duration, via the emergency scheduling provision of 21 USC 811(h):
N-[1-(2-Hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide (Beta-hydroxy-3-methylfentanyl), its optical isomers, salts and salts of isomers
US: Currently at CSA Schedule I Section b Subsection 12 Beta-hydroxy-3-methylfentanyl
Effective 29 May 1987, 52 FR 20070 revoked (and renumbered subsequent entries):
Effective 29 Nov 1986, 51 FR 42834 extended, for six months’ duration, the prior emergency scheduling:
Effective 29 Nov 1985, 50 FR 43698 added, for one years’ duration, via the emergency scheduling provision of 21 USC 811(h):
N-[3-Methyl-1-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide (3-Methylthiofentanyl), its optical isomers, salts and salts of isomers
US: Currently at CSA Schedule I Section b Subsection 35 3-Methylthiofentanyl
Effective 4 Jan 2013, 78 FR 664 revoked:
Effective 29 Feb 2012, 77 FR 12201 extended, for six months’ duration, the prior emergency scheduling:
5-(1,1-Dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (Cannabicyclohexanol; CP 47,497 C8 homologue), its optical, positional, and geometric isomers, salts and salts of isomers
Effective 1 Mar 2011, 76 FR 11075 replacement, for one year’s duration, via the emergency scheduling provision of 21 USC 811(h), for:
On 24 Nov 2010, 75 FR 71635 proposed replacement, for one year’s duration, via the emergency scheduling provision of 21 USC 811(h), for:
[Reserved]
Effective 29 Jun 2010, 75 FR 37300 replacement for:
Effective 29 May 1987, 52 FR 20070 renumbered:
Effective 29 Nov 1985, 50 FR 43698 added, for one years’ duration, via the emergency scheduling provision of 21 USC 811(h):
N-[1-(2-Thienyl)methyl-4-piperidyl]-N-phenylpropanamide (Thenylfentanyl) its optical and geometric isomers, salts and salts of isomers
This substance remained “scheduled” even though the legal authorization that placed it here (50 FR 43698) had expired decades earlier. After a quarter of a century, 75 FR 37300 ultimately banishes it.
Effective 13 Jan 2011, 76 FR 2287 corrected the prior notice of proposed scheduling, 75 FR 71635, by striking out parts addressing the Regulatory Flexibility Act and the Congressional Review Act on the grounds that neither Act applies to the proposal and are therefore immaterial.
While 75 FR 71635 proposed to add only five substances to Schedule I, final rule 76 FR 11075 casts the net rather wider, scheduling the original five and “…the optical, positional, and geometric isomers, salts and salts of isomers” of each. The final rule is silent about this incongruity.
Effective 29 May 1987, 52 FR 20070 revoked (and renumbered subsequent entries):
Effective 29 Nov 1986, 51 FR 42834 extended, for six months’ duration, the prior emergency scheduling:
Effective 29 Nov 1985, 50 FR 43698 added, for one years’ duration, via the emergency scheduling provision of 21 USC 811(h):
N-Phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]propanamide (Thiofentanyl), its optical isomers, salts and salts of isomers
US: Currently at CSA Schedule I Section b Subsection 53 Thiofentanyl
Effective 29 May 1987, 52 FR 20070 revoked (and renumbered subsequent entries):
Effective 10 Mar 1987, 52 FR 7270 extended, for six months’ duration, the prior emergency scheduling:
Effective 10 Mar 1986, 51 FR 4722 added, for one years’ duration, via the emergency scheduling provision of 21 USC 811(h):
N-(4-Fluorophenyl)-N-[1-(2-phenethyl)-4-piperidinyl]propanamide (Para-fluorofentanyl), its optical isomers, salts and salts of isomers
US: Currently at CSA Schedule I Section b Subsection 42 Para-fluorofentanyl
Effective 13 Apr 1989, 54 FR 14797 revoked (and renumbered subsequent entries):
Effective 13 Oct 1988, 53 FR 40061 extended, for six months’ duration, the prior emergency scheduling:
Effective 15 Oct 1987, 52 FR 38225 added, for one years’ duration, via the emergency scheduling provision of 21 USC 811(h):
3,4-Methylenedioxy-N-ethylamphetamine (N-Ethyl-alpha-methyl-3,4(methylenedioxy)phenethylamine; N-Ethyl MDA; MDE; MDEA)
US: Currently at CSA Schedule I Section d Subsection 12 3,4-Methylenedioxy-N-ethylamphetamine
Effective 13 Apr 1989, 54 FR 14797 revoked (and renumbered subsequent entries):
Effective 13 Oct 1988, 53 FR 40061 extended, for six months’ duration, the prior emergency scheduling:
Effective 15 Oct 1987, 52 FR 38225 added, for one years’ duration, via the emergency scheduling provision of 21 USC 811(h):
N-Hydroxy-3,4-methylenedioxyamphetamine (N-Hydroxy-alpha-methyl-3,4(methylenedioxy)phenethylamine; N-Hydroxy MDA)
US: Currently at CSA Schedule I Section d Subsection 13 N-Hydroxy-3,4-methylenedioxyamphetamine
Effective 13 Apr 1989, 54 FR 14797 revoked (and renumbered subsequent entries):
Effective 13 Oct 1988, 53 FR 40061 extended, for six months’ duration, the prior emergency scheduling:
Effective 15 Oct 1987, 52 FR 38225 added, for one years’ duration, via the emergency scheduling provision of 21 USC 811(h):
4-Methylaminorex (4,5-Dihydro-4-methyl-5-phenyl-2-oxazolamine)
US: Currently at CSA Schedule I Section f Subsection 6 (±)-cis-4-Methylaminorex
Effective 2 Feb 1990, 55 FR 3586 revoked (and renumbered subsequent entries):
Effective 2 Aug 1989, 54 FR 31815 extended, for six months’ duration, the prior emergency scheduling:
Effective 3 Aug 1988, 53 FR 29232 added, for one years’ duration, via the emergency scheduling provision of 21 USC 811(h):
N,N-Dimethylamphetamine (N,N-Alpha-trimethyl-benzeneethanamine; N,N-Alpha-trimethylphenethylamine), its optical isomers, salts and salts of isomers
US: Currently at CSA Schedule I Section f Subsection 8 N,N-Dimethylamphetamine
Effective 15 Oct 1993, 58 FR 53404 revoked (and renumbered subsequent entries):
Effective 1 May 1993, 58 FR 25934 extended, for six months’ duration, the prior emergency scheduling:
Effective 1 May 1992, 57 FR 18824 added, for one years’ duration, via the emergency scheduling provision of 21 USC 811(h):
Methcathinone (2-(Methylamino)propiophenone; Alpha-(methylamino)propiophenone; 2-(Methylamino)-1-phenylpropan-1-one; Alpha-N-methylaminopropiophenone; Monomethylpropion; Ephedrone; N-Methylcathinone; Methylcathinone; AL-464; AL-422; AL-463; UR1432), its optical isomers, salts and salts of isomers
US: Currently at CSA Schedule I Section f Subsection 5 Methcathinone
Effective 18 Mar 1994, 59 FR 12828 revoked (and renumbered subsequent entries):
Effective 21 Sep 1993, 58 FR 44611 extended, for six months’ duration, the prior emergency scheduling:
Effective 21 Sep 1992, 57 FR 43399 added, for one years’ duration, via the emergency scheduling provision of 21 USC 811(h):
Aminorex (Aminoxaphen; 2-Amino-5-phenyl-2-oxazoline; 4,5-Dihydro-5-phenyl-2-oxazolamine), its optical isomers, salts and salts of isomers
US: Currently at CSA Schedule I Section f Subsection 1 Aminorex
Effective 12 Sep 1994, 59 FR 46757 revoked (and renumbered subsequent entries):
Effective 12 Mar 1994, 59 FR 10720 extended, for six months’ duration, the prior emergency scheduling:
Effective 12 Mar 1993, 58 FR 13533 added, for one years’ duration, via the emergency scheduling provision of 21 USC 811(h):
Alpha-ethyltryptamine (Etryptamine; Monase; ɑ-Ethyl-1H-indole-3-ethanamine; 3-(2-Aminobutyl)indole; ɑ-ET; AET), its optical isomers, salts and salts of isomers
US: Currently at CSA Schedule I Section d Subsection 1 Alpha-ethyltryptamine
Effective 6 Jan 1995, 59 FR 65710 extended, for six months’ duration, the prior emergency scheduling:
Effective 2 Jun 1995, 60 FR 28718 revoked:
Effective 6 Jan 1994, 59 FR 671 added, for one years’ duration, via the emergency scheduling provision of 21 USC 811(h):
4-Bromo-2,5-dimethoxyphenethylamine (2-(4-Bromo-2,5-dimethoxyphenyl)-1-aminoethane; Alpha-desmethyl DOB; 2C-B; Nexus), its optical isomers, salts and salts of isomers
US: Currently at CSA Schedule I Section d Subsection 3 4-Bromo-2,5-dimethoxyphenethylamine
Effective 18 Mar 2004, 69 FR 12794 revoked:
Effective 20 Sep 2003, 68 FR 53289 extended, for six months’ duration, the prior emergency scheduling:
Effective 20 Sep 2002, 67 FR 59161 added, for one years’ duration, via the emergency scheduling provision of 21 USC 811(h):
N-Benzylpiperazine (BZP; 1-Benzylpiperazine), its optical isomers, salts and salts of isomers
US: Currently at CSA Schedule I Section f Subsection 2 N-Benzylpiperazine
Effective 18 Mar 2004, 69 FR 12794 revoked (and renumbered subsequent entries):
Effective 20 Sep 2003, 68 FR 53289 extended, for six months’ duration, the prior emergency scheduling:
Effective 20 Sep 2002, 67 FR 59161 added, for one years’ duration, via the emergency scheduling provision of 21 USC 811(h):
1-(3-Trifluoromethylphenyl)piperazine (TFMPP), its optical isomers, salts and salts of isomers
Effective 18 Mar 2004, 69 FR 12794 revoked (and renumbered subsequent entries):
Effective 20 Sep 2003, 68 FR 53289 extended, for six months’ duration, the prior emergency scheduling:
Effective 20 Sep 2002, 67 FR 59163 added, for one years’ duration, via the emergency scheduling provision of 21 USC 811(h):
2,5-Dimethoxy-4-(n)-propylthiophenenthylamine (2C-T-7), its optical isomers, salts and salts of isomers
US: Currently at CSA Schedule I Section d Subsection 6 2,5-Dimethoxy-4-(n)-propylthiophenenthylamine
Effective 29 Sep 2004, 69 FR 58050 revoked:
Effective 1 Apr 2004, 69 FR 17034 extended, for six months’ duration, the prior emergency scheduling:
Effective 4 Apr 2003, 68 FR 16427 added, for one years’ duration, via the emergency scheduling provision of 21 USC 811(h):
Alpha-methyltryptamine (AMT), its isomers, salts, and salts of isomers
US: Currently at CSA Schedule I Section d Subsection 16 Alpha-methyltryptamine
Effective 29 Sep 2004, 69 FR 58050 revoked:
Effective 1 Apr 2004, 69 FR 17034 added, for one years’ duration, via the emergency scheduling provision of 21 USC 811(h):
Effective 4 Apr 2003, 68 FR 16427 added, for one years’ duration, via the emergency scheduling provision of 21 USC 811(h):
5-Methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT), its isomers, salts, and salts of isomers
US: Currently at CSA Schedule I Section d Subsection 20 5-Methoxy-N,N-diisopropyltryptamine
Effective 4 Jan 2013, 78 FR 664 revoked:
Effective 29 Feb 2012, 77 FR 12201 extended, for six months’ duration, the prior emergency scheduling:
Effective 1 Mar 2011, 76 FR 11075 added, for one years’ duration, via the emergency scheduling provision of 21 USC 811(h):
Effective 13 Jan 2011, 76 FR 2287 corrected the prior notice of proposed scheduling, 75 FR 71635, by striking out parts addressing the Regulatory Flexibility Act and the Congressional Review Act on the grounds that neither Act applies to the proposal and are therefore immaterial.
On 24 Nov 2010, 75 FR 71635 proposed to add, for one years’ duration, via the emergency scheduling provision of 21 USC 811(h):
1-Butyl-3-(1-naphthoyl)indole (JWH-073), its optical, positional, and geometric isomers, salts and salts of isomers
While 75 FR 71635 proposed to add only five substances to Schedule I, final rule 76 FR 11075 casts the net rather wider, scheduling the original five and “…the optical, positional, and geometric isomers, salts and salts of isomers” of each. The final rule is silent about this incongruity.
US: Currently at CSA Schedule I Section g Subsection 4 1-Butyl-3-(1-naphthoyl)indole
Effective 4 Jan 2013, 78 FR 664 revoked:
Effective 29 Feb 2012, 77 FR 12201 extended, for six months’ duration, the prior emergency scheduling:
Effective 1 Mar 2011, 76 FR 11075 added, for one years’ duration, via the emergency scheduling provision of 21 USC 811(h):
Effective 13 Jan 2011, 76 FR 2287 corrected the prior notice of proposed scheduling, 75 FR 71635, by striking out parts addressing the Regulatory Flexibility Act and the Congressional Review Act on the grounds that neither Act applies to the proposal and are therefore immaterial.
On 24 Nov 2010, 75 FR 71635 proposed to add, for one years’ duration, via the emergency scheduling provision of 21 USC 811(h):
1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole (JWH-200), its optical, positional, and geometric isomers, salts and salts of isomers
While 75 FR 71635 proposed to add only five substances to Schedule I, final rule 76 FR 11075 casts the net rather wider, scheduling the original five and “…the optical, positional, and geometric isomers, salts and salts of isomers” of each. The final rule is silent about this incongruity.
US: Currently at CSA Schedule I Section g Subsection 6 1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole
Effective 4 Jan 2013, 78 FR 664 revoked:
Effective 29 Feb 2012, 77 FR 12201 extended, for six months’ duration, the prior emergency scheduling:
Effective 1 Mar 2011, 76 FR 11075 added, for one years’ duration, via the emergency scheduling provision of 21 USC 811(h):
Effective 13 Jan 2011, 76 FR 2287 corrected the prior notice of proposed scheduling, 75 FR 71635, by striking out parts addressing the Regulatory Flexibility Act and the Congressional Review Act on the grounds that neither Act applies to the proposal and are therefore immaterial.
On 24 Nov 2010, 75 FR 71635 proposed to add, for one years’ duration, via the emergency scheduling provision of 21 USC 811(h):
1-Pentyl-3-(1-naphthoyl)indole (JWH-018), its optical, positional, and geometric isomers, salts and salts of isomers
While 75 FR 71635 proposed to add only five substances to Schedule I, final rule 76 FR 11075 casts the net rather wider, scheduling the original five and “…the optical, positional, and geometric isomers, salts and salts of isomers” of each. The final rule is silent about this incongruity.
US: Currently at CSA Schedule I Section g Subsection 3 1-Pentyl-3-(1-naphthoyl)indole
Effective 4 Jan 2013, 78 FR 664 revoked:
Effective 21 Oct 2011, 76 FR 65371 added, for one years’ duration, via the emergency scheduling provision of 21 USC 811(h):
On 8 Sep 2011, 76 FR 55616 proposed to add, for one years’ duration, via the emergency scheduling provision of 21 USC 811(h):
4-Methyl-N-methylcathinone (Mephedrone)
US: Currently at CSA Schedule I Section d Subsection 36 4-Methylmethcathinone
Effective 20 Mar 2015, 80 FR 14842 revoked:
Effective 4 Jan 2013, 78 FR 664 renumbered:
Effective 18 Oct 2012, 77 FR 64032 extended, for six months’ duration, the prior emergency scheduling:
Effective 21 Oct 2011, 76 FR 65371 added, for one years’ duration, via the emergency scheduling provision of 21 USC 811(h):
On 8 Sep 2011, 76 FR 55616 proposed to add, for one years’ duration, via the emergency scheduling provision of 21 USC 811(h):
3,4-Methylenedioxy-N-methylcathinone (Methylone)
US: Currently at CSA Schedule I Section d Subsection 47 3,4-Methylenedioxy-N-methylcathinone
Effective 4 Jan 2013, 78 FR 664 revoked:
Effective 21 Oct 2011, 76 FR 65371 added, for one years’ duration, via the emergency scheduling provision of 21 USC 811(h):
On 8 Sep 2011, 76 FR 55616 proposed to add, for one years’ duration, via the emergency scheduling provision of 21 USC 811(h):
3,4-Methylenedioxypyrovalerone (MDPV)
US: Currently at CSA Schedule I Section d Subsection 37 3,4-Methylenedioxypyrovalerone
Effective 15 May 2015, 80 FR 27854 extended, for one years’ duration, the prior emergency scheduling:
On 14 May 2015, 80 FR 27611 proposed to revoke (and to renumber subsequent entries:)
Effective 20 Mar 2015, 80 FR 14842 renumbered:
(1)
7144
(1-Pentyl-1H-indol-3-yl)(2,2,3,3-
tetramethylcyclopropyl)methanone (UR-144; 1-Pentyl-3-(2,2,3,3-tetramethylcyclopropoyl)indole), its optical, positional, and geometric isomers, salts and salts of isomers
Effective 16 May 2013, 78 FR 28735 replacement, for two year’s duration, via the emergency scheduling provision of 21 USC 811(h), for:
1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone (UR-144; 1-Pentyl-3-(2,2,3,3-tetramethylcyclopropoyl)indole), its optical, positional, and geometric isomers, salts and salts of isomers
On 12 Apr 2013, 78 FR 21858 proposed to add, for two years’ duration, via the emergency scheduling provision of 21 USC 811(h):
Note: The name in the proposed rule is incorrect—it ought to begin with a left parenthethis. This error is corrected in the final rule.
CA: CDSA Schedule II Section 2 Subsection 6 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-
tetramethylcyclopropyl)-methanone
UK: MDA Part II Class B Section 1(c) UR-144
See also CSA Schedule I Section g Subsection 16 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-
tetramethylcyclopropyl)methanone
Effective 15 May 2015, 80 FR 27854 extended, for one years’ duration, the prior emergency scheduling:
On 14 May 2015, 80 FR 27611 proposed to revoke (and to renumber subsequent entries:)
Effective 20 Mar 2015, 80 FR 14842 renumbered:
(2)
7011
[1-(5-Fluoro-pentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone (5-Fluoro-UR-144; 5-F-UR-144; XLR11; 1-(5-Fluoro-pentyl)-3-(2,2,3,3-tetramethylcyclopropoyl)indole), its optical, positional, and geometric isomers, salts and salts of isomers
Effective 16 May 2013, 78 FR 28735 replacement, for two year’s duration, via the emergency scheduling provision of 21 USC 811(h), for:
1-(5-Fluoro-pentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone (5-Fluoro-UR-144; 5-F-UR-144; XLR11; 1-(5-Fluoro-pentyl)-3-(2,2,3,3-tetramethylcyclopropoyl)indole), its optical, positional, and geometric isomers, salts and salts of isomers
On 12 Apr 2013, 78 FR 21858 proposed to add, for two years’ duration, via the emergency scheduling provision of 21 USC 811(h):
Note: The name in the proposed rule is incorrect—it ought to begin with a left square bracket, and the hyphen in “Fluoro-pentyl” appears superfluous. The first mistake is corrected in the final rule.
CA: CDSA Schedule II Section 2 Subsection 6 [1-(5-Fluoro-pentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)-methanone
UK: MDA Part II Class B Section 1(c) XLR11
See also CSA Schedule I Section g Subsection 17 [1-(5-Fluoro-pentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone
Effective 15 May 2015, 80 FR 27854 extended, for one years’ duration, the prior emergency scheduling:
On 14 May 2015, 80 FR 27611 proposed to revoke (and to renumber subsequent entries:)
Effective 20 Mar 2015, 80 FR 14842 renumbered:
(3)
7048
N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide (APINACA; AKB48), its optical, positional, and geometric isomers, salts and salts of isomers
Effective 16 May 2013, 78 FR 28735 replacement, for two year’s duration, via the emergency scheduling provision of 21 USC 811(h), for:
N-Adamantyl-1-pentyl-1H-indazole-3-carboxamide (APINACA; AKB48), its optical, positional, and geometric isomers, salts and salts of isomers
On 12 Apr 2013, 78 FR 21858 proposed to add, for two years’ duration, via the emergency scheduling provision of 21 USC 811(h):
Note: There is a subtle change in the name between the proposed and final rules. While it might be argued the proposed rule describes both the 1- and 2-adamantyl isomers, the final rule specifically names only the former.
CA: CDSA Schedule II Section 2 Subsection 8 N-(Adamantan-1-yl)-1-pentyl-1H-indazole-3-carboxamide
See also CSA Schedule I Section g Subsection 18 N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide
⇒
PubChem: 57404063; ChemSpider: 28189076; Bluelight: AKB48; Drugs Forum: AKB48; Wikipedia: AKB48 (drug)
On 13 Nov 2015, 80 FR 70649 proposed to revoke:
Effective 13 Nov 2015, 80 FR 70657 extended, for one years’ duration, the prior emergency scheduling:
Effective 20 Mar 2015, 80 FR 14842 renumbered:
Effective 15 Nov 2013, 78 FR 68716 added, for two years’ duration, via the emergency scheduling provision of 21 USC 811(h):
On 10 Oct 2013, 78 FR 61991 proposed to add, for two years’ duration, via the emergency scheduling provision of 21 USC 811(h):
(4)
7538
2-(4-Iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25I-NBOMe; 2C-I-NBOMe; 25I; Cimbi-5), its optical, positional, and geometric isomers, salts and salts of isomers
EU: Substances Substances 2-(4-Iodo-2,5-dimethoxy)-N-(2-methoxybenzyl) phenethylamine
UK: MDA Part I Class A Section 1(f) 2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
UK: [revoked] MDA Temporary Class Drug Orders 2013 2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
See also CSA Schedule I Section d Subsection 48 2-(4-Iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
On 13 Nov 2015, 80 FR 70649 proposed to revoke:
Effective 13 Nov 2015, 80 FR 70657 extended, for one years’ duration, the prior emergency scheduling:
Effective 20 Mar 2015, 80 FR 14842 renumbered:
Effective 15 Nov 2013, 78 FR 68716 added, for two years’ duration, via the emergency scheduling provision of 21 USC 811(h):
On 10 Oct 2013, 78 FR 61991 proposed to add, for two years’ duration, via the emergency scheduling provision of 21 USC 811(h):
(5)
7537
2-(4-Chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25C-NBOMe; 2C-C-NBOMe; 25C; Cimbi-82), its optical, positional, and geometric isomers, salts and salts of isomers
UK: MDA Part I Class A Section 1(f) 2-(4-Chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
UK: [revoked] MDA Temporary Class Drug Orders 2013 2-(4-Chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
See also CSA Schedule I Section d Subsection 49 2-(4-Chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
On 13 Nov 2015, 80 FR 70649 proposed to revoke:
Effective 13 Nov 2015, 80 FR 70657 extended, for one years’ duration, the prior emergency scheduling:
Effective 20 Mar 2015, 80 FR 14842 renumbered:
Effective 15 Nov 2013, 78 FR 68716 added, for two years’ duration, via the emergency scheduling provision of 21 USC 811(h):
On 10 Oct 2013, 78 FR 61991 proposed to add, for two years’ duration, via the emergency scheduling provision of 21 USC 811(h):
(6)
7536
2-(4-Bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25B-NBOMe; 2C-B-NBOMe; 25B; Cimbi-36), its optical, positional, and geometric isomers, salts and salts of isomers
UK: MDA Part I Class A Section 1(f) 2-(4-Bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
UK: [revoked] MDA Temporary Class Drug Orders 2013 2-(4-Bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
See also CSA Schedule I Section d Subsection 50 2-(4-Bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
Effective 20 Mar 2015, 80 FR 14842 renumbered:
Effective 10 Feb 2014, 79 FR 7577 added, for two years’ duration, via the emergency scheduling provision of 21 USC 811(h):
On 10 Jan 2014, 79 FR 1776 proposed to add, for two years’ duration, via the emergency scheduling provision of 21 USC 811(h):
(7)
7222
Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate (PB-22; QUPIC), its optical, positional, and geometric isomers, salts and salts of isomers
CA: CDSA Schedule II Section 2 Subsection 7 1-Pentyl-8-quinolinyl ester-1H-indole-3-carboxylic acid
Effective 5 Feb 2016, 81 FR 6175 extended, for one years’ duration, the prior emergency scheduling:
Effective 20 Mar 2015, 80 FR 14842 renumbered:
Effective 10 Feb 2014, 79 FR 7577 added, for two years’ duration, via the emergency scheduling provision of 21 USC 811(h):
On 10 Jan 2014, 79 FR 1776 proposed to add, for two years’ duration, via the emergency scheduling provision of 21 USC 811(h):
(8)
7225
Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (5-Fluoro-PB-22; 5F-PB-22), its optical, positional, and geometric isomers, salts and salts of isomers
CA: CDSA Schedule II Section 2 Subsection 7 1-(5-Fluoropentyl)-8-quinolinyl ester-1H-indole-3-carboxylic acid
Effective 20 Mar 2015, 80 FR 14842 renumbered:
Effective 10 Feb 2014, 79 FR 7577 added, for two years’ duration, via the emergency scheduling provision of 21 USC 811(h):
On 10 Jan 2014, 79 FR 1776 proposed to add, for two years’ duration, via the emergency scheduling provision of 21 USC 811(h):
(9)
7012
N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (AB-FUBINACA), its optical, positional, and geometric isomers, salts and salts of isomers
CA: CDSA Schedule II Section 2 Subsection 8 N-(1-(Aminocarbonyl)-2-methylpropyl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide
Effective 20 Mar 2015, 80 FR 14842 renumbered:
Effective 10 Feb 2014, 79 FR 7577 added, for two years’ duration, via the emergency scheduling provision of 21 USC 811(h):
On 10 Jan 2014, 79 FR 1776 proposed to add, for two years’ duration, via the emergency scheduling provision of 21 USC 811(h):
(10)
7035
Effective 20 Mar 2015, 80 FR 14842 renumbered:
Effective 7 Mar 2014, 79 FR 12938 added, for two years’ duration, via the emergency scheduling provision of 21 USC 811(h):
On 28 Jan 2014, 79 FR 4429 proposed to add, for two years’ duration, via the emergency scheduling provision of 21 USC 811(h):
(11)
1249
4-Methyl-N-ethylcathinone (4-MEC; 2-(Ethylamino)-1-(4-methylphenyl)propan-1-one), its optical, positional, and geometric isomers, salts and salts of isomers
⇒
PubChem: 52988259; ChemSpider: 25630091; Drugs Forum: (4-MEC); Erowid: 4-Methylethcathinone (4-MEC); Wikipedia: 4-Methylethcathinone
Effective 20 Mar 2015, 80 FR 14842 renumbered:
Effective 7 Mar 2014, 79 FR 12938 added, for two years’ duration, via the emergency scheduling provision of 21 USC 811(h):
On 28 Jan 2014, 79 FR 4429 proposed to add, for two years’ duration, via the emergency scheduling provision of 21 USC 811(h):
(12)
7498
4-Methyl-alpha-pyrrolidinopropiophenone (4-MePPP; MePPP; 4-Methyl-α-pyrrolidinopropiophenone; 1-(4-Methylphenyl)-2-(pyrrolidin-1-yl)-propan-1-one), its optical, positional, and geometric isomers, salts and salts of isomers
Strictly speaking, the hyphen between (pyrrolidin-1-yl) and propan-1-one is syntactically incorrect if semantically innocuous.
Effective 20 Mar 2015, 80 FR 14842 renumbered:
Effective 7 Mar 2014, 79 FR 12938 added, for two years’ duration, via the emergency scheduling provision of 21 USC 811(h):
On 28 Jan 2014, 79 FR 4429 proposed to add, for two years’ duration, via the emergency scheduling provision of 21 USC 811(h):
(13)
7545
alpha-Pyrrolidinopentiophenone (α-PVP; α-Pyrrolidinopentiophenone; 1-Phenyl-2-(pyrrolidin-1-yl)pentan-1-one), its optical, positional, and geometric isomers, salts and salts of isomers
Note to hardcore IUPAC junkies: The name given for this substance, like many latter-day cathinones, is a real dog’s breakfast. is not a valid IUPAC name and I suspect never was. I’m guessing it is a recent invention, what linguists call a “back-formation,” patterned after the valid IUPAC name .
derives from the older, now deprecated name for propanoic acid, . It is easy to see how might follow as the name for the four-carbon homologue. In fact is the correct name, derived from , the deprecated name for butanoic acid.
Similarly, is also incorrect. The deprecated name for the five-carbon homologue (pentanoic acid) is , from which derives the correct name . The trivial name pyrovalerone is a contraction of the deprecated (but still valid) name %CE%B1-pyrrolidino-p-methylvalerophenone.
I am indebted to coder extraordinaire Daniel Lowe and his Open Parser for Systematic IUPAC nomenclature (OPSIN), which makes exploring IUPAC nomenclature if not fun, entertaining at least.
⇒
PubChem: 11148955; ChemSpider: 9324063; Drugs Forum: α-PVP; Wikipedia: alpha-Pyrrolidinopentiophenone
Effective 20 Mar 2015, 80 FR 14842 renumbered:
Effective 7 Mar 2014, 79 FR 12938 added, for two years’ duration, via the emergency scheduling provision of 21 USC 811(h):
On 28 Jan 2014, 79 FR 4429 proposed to add, for two years’ duration, via the emergency scheduling provision of 21 USC 811(h):
(14)
7541
Effective 20 Mar 2015, 80 FR 14842 renumbered:
Effective 7 Mar 2014, 79 FR 12938 added, for two years’ duration, via the emergency scheduling provision of 21 USC 811(h):
On 28 Jan 2014, 79 FR 4429 proposed to add, for two years’ duration, via the emergency scheduling provision of 21 USC 811(h):
(15)
1246
Pentedrone (α-Methylaminovalerophenone; 2-(Methylamino)-1-phenylpentan-1-one), its optical, positional, and geometric isomers, salts and salts of isomers
⇒
PubChem: 57501499; ChemSpider: 26286729; Bluelight: Pentedrone; Drugs Forum: Pentedrone; Wikipedia: Pentedrone
Effective 20 Mar 2015, 80 FR 14842 renumbered:
Effective 7 Mar 2014, 79 FR 12938 added, for two years’ duration, via the emergency scheduling provision of 21 USC 811(h):
On 28 Jan 2014, 79 FR 4429 proposed to add, for two years’ duration, via the emergency scheduling provision of 21 USC 811(h):
(16)
7542
Effective 20 Mar 2015, 80 FR 14842 renumbered:
Effective 7 Mar 2014, 79 FR 12938 added, for two years’ duration, via the emergency scheduling provision of 21 USC 811(h):
On 28 Jan 2014, 79 FR 4429 proposed to add, for two years’ duration, via the emergency scheduling provision of 21 USC 811(h):
(17)
1238
4-Fluoro-N-methylcathinone (4-FMC; Flephedrone; 1-(4-Fluorophenyl)-2-(methylamino)propan-1-one), its optical, positional, and geometric isomers, salts and salts of isomers
UK: MDA Part II Class B Section 1(aa) Flephedrone
⇒
PubChem: 49853406; ChemSpider: 21477355; Drugs Forum: Flephedrone; Erowid: 4-Fluoromethcathinone (4-FMC); Wikipedia: 4-Fluoromethcathinone
Effective 20 Mar 2015, 80 FR 14842 renumbered:
Effective 7 Mar 2014, 79 FR 12938 added, for two years’ duration, via the emergency scheduling provision of 21 USC 811(h):
On 28 Jan 2014, 79 FR 4429 proposed to add, for two years’ duration, via the emergency scheduling provision of 21 USC 811(h):
(18)
1233
3-Fluoro-N-methylcathinone (3-FMC; 1-(3-Fluorophenyl)-2-(methylamino)propan-1-one), its optical, positional, and geometric isomers, salts and salts of isomers
Effective 20 Mar 2015, 80 FR 14842 renumbered:
Effective 7 Mar 2014, 79 FR 12938 added, for two years’ duration, via the emergency scheduling provision of 21 USC 811(h):
On 28 Jan 2014, 79 FR 4429 proposed to add, for two years’ duration, via the emergency scheduling provision of 21 USC 811(h):
(19)
1258
Naphyrone (Naphthylpyrovalerone; 1-(Naphthalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one), its optical, positional, and geometric isomers, salts and salts of isomers
UK: MDA Part II Class B Section 1(ab) Naphthylpyrovalerone
Effective 20 Mar 2015, 80 FR 14842 renumbered:
Effective 7 Mar 2014, 79 FR 12938 added, for two years’ duration, via the emergency scheduling provision of 21 USC 811(h):
On 28 Jan 2014, 79 FR 4429 proposed to add, for two years’ duration, via the emergency scheduling provision of 21 USC 811(h):
(20)
7546
alpha-Pyrrolidinobutiophenone (α-PBP; 1-Phenyl-2-(pyrrolidin-1-yl)butan-1-one), its optical, positional, and geometric isomers, salts and salts of isomers
Note to hardcore IUPAC junkies: The name given for this substance, like many latter-day cathinones, is a real dog’s breakfast. is not a valid IUPAC name and I suspect never was. I’m guessing it is a recent invention, what linguists call a “back-formation,” patterned after the valid IUPAC name .
derives from the older, now deprecated name for propanoic acid, . It is easy to see how might follow as the name for the four-carbon homologue. In fact is the correct name, derived from , the deprecated name for butanoic acid.
Similarly, is also incorrect. The deprecated name for the five-carbon homologue (pentanoic acid) is , from which derives the correct name . The trivial name pyrovalerone is a contraction of the deprecated (but still valid) name %CE%B1-pyrrolidino-p-methylvalerophenone.
I am indebted to coder extraordinaire Daniel Lowe and his Open Parser for Systematic IUPAC nomenclature (OPSIN), which makes exploring IUPAC nomenclature if not fun, entertaining at least.
Effective 20 Mar 2015, 80 FR 14842 renumbered:
Effective 30 Jan 2015, 80 FR 5042 added, for two years’ duration, via the emergency scheduling provision of 21 USC 811(h):
On 19 Dec 2014, 79 FR 75767 proposed to add, for two years’ duration, via the emergency scheduling provision of 21 USC 811(h):
(21)
7031
N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (AB-CHMINACA), its optical, positional and geometric isomers, salts and salts of isomers
Effective 20 Mar 2015, 80 FR 14842 renumbered:
Effective 30 Jan 2015, 80 FR 5042 added, for two years’ duration, via the emergency scheduling provision of 21 USC 811(h):
On 19 Dec 2014, 79 FR 75767 proposed to add, for two years’ duration, via the emergency scheduling provision of 21 USC 811(h):
(22)
7023
N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB-PINACA), its optical, positional and geometric isomers, salts and salts of isomers
CA: CDSA Schedule II Section 2 Subsection 8 N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide
methanone](data:image/png;base64,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 "Click for a 3D rendering of [1-(5-Fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone")
Effective 20 Mar 2015, 80 FR 14842 renumbered:
Effective 30 Jan 2015, 80 FR 5042 added, for two years’ duration, via the emergency scheduling provision of 21 USC 811(h):
On 19 Dec 2014, 79 FR 75767 proposed to add, for two years’ duration, via the emergency scheduling provision of 21 USC 811(h):
(23)
7024
Effective 17 Jul 2015, 80 FR 42381 added:
On 21 May 2015, 80 FR 29227 proposed to add:
(24)
9821
N-(1-Phenethylpiperidin-4-yl)-N-phenylacetamide (Acetyl fentanyl), its optical, positional, and geometric isomers, salts and salts of isomers
On 16 Sep 2015, 80 FR 55565 proposed to add, for two years’ duration, via the emergency scheduling provision of 21 USC 811(h):
(25)
7032
N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (MAB-CHMINACA; ADB-CHMIINACA), its optical, positional, and geometric isomers, salts and salts of isomers
11 March 2016 · 
· Isomer Design
· Isomer Design